MRK Jun 2024 130.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
At close: 03:59PM EDT
| Previous close | 1.4200 |
| Open | 1.4500 |
| Bid | 1.6300 |
| Ask | 1.8000 |
| Strike | 130.00 |
| Expiry date | 2024-06-28 |
| Day's range | 1.1000 - 2.2000 |
| Contract range | N/A |
| Volume | |
| Open interest | 2.07k |
Simply Wall St.With 78% ownership of the shares, Merck & Co., Inc. (NYSE:MRK) is heavily dominated by institutional owners
Key Insights Given the large stake in the stock by institutions, Merck's stock price might be vulnerable to their...
- Yahoo Finance Video
FDA approves Merck's pneumonia vaccine for adults
The Food and Drug Administration (FDA) has approved Merck's (MRK) new vaccine to protect adults from pneumonia. Yahoo Finance's Anjalee Khemlani reports more on how the vaccine works as the pharmaceutical company awaits the Centers for Disease Control's (CDC) recommendation. For more expert insight and the latest market action, click here to watch this full episode of Catalysts. This post was written by Melanie Riehl
ZacksMerck's (MRK) 21-Valent Pneumococcal Jab Gets FDA Approval
Merck's (MRK) 21-valent pneumococcal conjugate vaccine, Capvaxive/V116, becomes the first PCV specifically designed for adults to be approved by the FDA.
© 2024 Yahoo. All rights reserved.